Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meeting will be held as a teleconference only and is open to
the public to dial-in for participation. Individuals who plan to dial-
in to the meeting and need special assistance or other reasonable
accommodations in order to do so, should notify the Contact Person
listed below in advance of the meeting.
Name of Committee: National Cancer Institute Board of Scientific
Advisors; Ad Hoc Subcommittee on HIV and AIDS Malignancy.
Date: May 24, 2019.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To discuss recommendations of the BSA Ad Hoc Working
Group on Immunology of Therapies & Vaccines and Research Structure.
Place: National Institutes of Health, Building 10, Room 6N106,
10 Center Drive, Bethesda, MD 20892 (Telephone Conference Call).
Dial: 1-650-479-3207, Access Code: 732 082 860.
Contact Person: Robert Yarchoan, M.D., Director, Office of HIV
and AIDS Malignancy, Office of the Director, Chief, HIV and AIDS
Malignancy Branch, Center for Cancer Research, National Cancer
Institute, Building 10, Room 6N106, 10 Center Drive, Bethesda, MD
20892, 240-496-0328, Robert.Yarchoan@nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/bsa/bsa.htm, where an
agenda and any additional information for the meeting will be posted